Literature DB >> 6846307

Chlamydia trachomatis in the ascitic fluid of patients with chronic liver disease.

J M Shabot, G D Roark, A L Truant.   

Abstract

Several recent reports suggest that Chlamydia trachomatis causes peritonitis and perihepatitis in young women. We studied nine patients with chronic liver disease and ascites to determine a possible role for C. trachomatis in the bacterial peritonitis of cirrhotic patients. C. trachomatis was isolated and identified from the peritoneal fluid in three of these patients. In these patients, the peritoneal fluid was a transudate that contained fewer than 250 white blood cells/mm3, with fewer than 10% neutrophils, except when a bacterial organism other than C. trachomatis was also present. Two of these patients developed peritonitis that was associated with other bacterial organisms. Unless specific tests for C. trachomatis was performed, its presence will not be detected, and the peritoneal fluid cell count will not suggest bacterial infection.

Entities:  

Mesh:

Year:  1983        PMID: 6846307

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin.

Authors:  Yuriy K Bashmakov; Nailya A Zigangirova; Yulia P Pashko; Lidia N Kapotina; Ivan M Petyaev
Journal:  Comp Hepatol       Date:  2010-01-28

Review 2.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 3.  Recent advances in Chlamydia trachomatis.

Authors:  S Ladany; I Sarov
Journal:  Eur J Epidemiol       Date:  1985-12       Impact factor: 8.082

4.  Detection of C. trachomatis in the serum of the patients with urogenital chlamydiosis.

Authors:  Naylia A Zigangirova; Yulia P Rumyantseva; Elena Y Morgunova; Lidia N Kapotina; Lubov V Didenko; Elena A Kost; Ekaterina A Koroleva; Yuriy K Bashmakov; Ivan M Petyaev
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.